These data suggest that skeletal muscle SOCS3 is increased in conditions associated with obesity and insulin resistance, and may be an important molecule mediating obesity-, lipid-, and cytokine-induced insulin resistance. Here, SOCS3 is linked to obesity due to melanocortin 4 receptor deficiency.